P1.20. Leveraging NLP to Identify Biomarker-Eligible Patients - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
John Ruckdeschel
Meta Tag
Speaker John Ruckdeschel
Topic Pathology & Biomarkers: Artificial Intelligence in Pathology
biomarker-eligible patients
clinical trial
natural language processing
artificial intelligence
phase II prospective trial
genomic targets
advanced cancers
physician notes
Electronic Health Record
Powered By